{"symbol":"ABT","fiscalQuarter":"Q1-2022","reportDate":"2022-04-20","reportTime":"BMO","status":"reported","company":{"name":"Abbott Laboratories","sector":"Health Care","industry":"Health Care Equipment"},"tier":"free","webUrl":"https://earningsnxt.ai/ticker/ABT/earnings/Q1-2022","postBrief":{"headline":"Abbott Laboratories Beats on EPS, Stock Up 2.22%","keyNumbers":[{"metric":"EPS","actual":"$1.73","expected":"N/A","surprise":"+17.77%"},{"metric":"Revenue","actual":"N/A","expected":"N/A","surprise":"N/A"}],"managementCommentary":{"tone":"Unknown","keyQuotes":[],"summary":"No transcript is on record, and the analysis is based on numerical results only."},"guidanceChanges":{"summary":"No guidance data is available.","changes":[]},"whatItMeans":"Abbott Laboratories reported a strong earnings per share, exceeding expectations by nearly 18%. The stock reacted positively, rising by 2.22%. However, without revenue data or management commentary, it\u2019s difficult to assess the overall performance and future outlook.","metaDescription":"Abbott Laboratories (ABT) Q1 2022 earnings: EPS beat by 17.77%. Stock up 2.22%. Full breakdown."}}